AJMC November 21, 2023
Hayden E. Klein

Chase Hendrickson, MD, MPH, Vanderbilt University Medical Center, attributes gaps in continuous glucose monitoring (CGM) prescribing rates to patient demographics, endocrinologists’ longer familiarity with the technology, and the availability of ancillary support in endocrine clinics.

Chase Hendrickson, MD, MPH, endocrinologist, assistant professor of medicine, and executive medical director of the Medicine Patient Care Center at Vanderbilt University Medical Center, highlights barriers in continuous glucose monitor (CGM) prescribing rates between endocrinology and primary care settings.

Transcript

Why are CGM uptake rates lower in primary care settings compared with endocrinology clinics, and how can these barriers be addressed?

I recently had the chance to participate in some research that Lindsay Mayberry (PhD, MS) here at Vanderbilt led, and it was looking at...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Digital Health, Provider, Technology, Trends, Wearables
Oura Ring Is ‘Like An Apple Product’ And Could Take Key Health Metric Mainstream
Wearable ultrasound sensor revolutionizes continuous blood pressure monitoring
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review

Share This Article